David Young - Net Worth and Insider Trading
David Young Net Worth
The estimated net worth of David Young is at least $300,359 dollars as of 2024-04-29. David Young is the Pres. Research & Development of Processa Pharmaceuticals Inc and owns about 139,702 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $300,359. Details can be seen in David Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Young has not made any transactions after 2024-02-07 and currently still holds the listed stock(s).
Transaction Summary of David Young
David Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Young owns 1 companies in total, including Processa Pharmaceuticals Inc (PCSA) .
Click here to see the complete history of David Young’s form 4 insider trades.
Insider Ownership Summary of David Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2024-02-07 | director & 10 percent owner & President & CEO |
David Young Latest Holdings Summary
David Young currently owns a total of 1 stock. David Young owns 139,702 shares of Processa Pharmaceuticals Inc (PCSA) as of February 7, 2024, with a value of $300,359.
Latest Holdings of David Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2024-02-07 | 139,702 | 2.15 | 300,359 |
Holding Weightings of David Young
David Young Form 4 Trading Tracker
According to the SEC Form 4 filings, David Young has made a total of 6 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 21,000 shares on February 7, 2024, which cost David Young around $51,450.
Insider Trading History of David Young
- 1
David Young Trading Performance
GuruFocus tracks the stock performance after each of David Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Young is -14.82%. GuruFocus also compares David Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Young within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Young's insider trading performs compared to the benchmark.
Performance of David Young
Average Return
-75.76%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.82 | -14.82 | -5.66 | -75.76 | -74.61 | |
| Relative Return to S&P 500(%) | -0.26 | -21.16 | -12.51 | -88.05 | -75.86 |
David Young Ownership Network
Ownership Network List of David Young
Ownership Network Relation of David Young
David Young Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
David Young is the director & 10 percent owner & President & CEO of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include Chief Business - Strategy Off Patrick Lin , Chief Executive Officer George K Ng , and Chief Administrative Officer Wendy Guy .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, David Young made 5 insider transaction in Processa Pharmaceuticals Inc (PCSA) with a net purchase of 161,000. Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 10,000 shares made by George K Ng , a net purchase of 8,000 shares made by Justin W Yorke , and a net purchase of 4,000 shares made by Patrick Lin .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 63,000 shares, with a net purchase of 63,000 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 69,000 shares were bought by its insiders, resulting in a net purchase of 69,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
David Young Mailing Address
Above is the net worth, insider trading, and ownership report for David Young. You might contact David Young via mailing address: 8850 Stanford Boulevard, Suite 2500, Columbia Md 21045.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
